Caffeine Shampoo: What the Trials Actually Show
Topical caffeine penetrates the hair follicle within two to five minutes and counteracts DHT-induced follicle suppression in laboratory models. A 2017 open-label trial in 210 men found a 0.2 percent caffeine liquid non-inferior to 5 percent minoxidil over six months, with anagen hair improving 10.59 percent against 11.68 percent. But a 2025 systematic review of nine studies found the evidence mostly low to very low quality, and the shampoo trials all tested caffeine combined with adenosine or DMG-Na, so the effect cannot be assigned to caffeine alone.
Caffeine shampoo is sold as a simple story: caffeine wakes up the follicle, the follicle grows hair, the shampoo is the delivery system. The laboratory story is real. The clinical story is thinner than the bottle suggests, and the gap between the two is where most of the marketing lives.
The foundation is a 2007 study by Fischer and colleagues in the International Journal of Dermatology. Caffeine reached the hair follicle within two minutes of contact, and the follicle acted as a preferred route compared with the surrounding skin. In vitro, caffeine at 0.001 to 0.005 percent counteracted DHT-induced suppression of hair shaft elongation in cultured follicles. Those concentrations are far lower than the 0.2 to 1 percent found in commercial products, which is the first hint that the dose story is not as simple as the label makes it look.
The trial that gets quoted everywhere
The study everyone cites is the 2017 Dhurat trial, published in Skin Pharmacology and Physiology. Researchers randomized 210 men with androgenetic alopecia to either a 0.2 percent caffeine-based topical liquid or 5 percent topical minoxidil for six months, measuring the change in the percentage of hairs in the anagen, or active growth, phase. The caffeine group improved 10.59 percent, the minoxidil group 11.68 percent, and the caffeine liquid met the trial's predefined non-inferiority criterion.
The limitations matter as much as the results. The trial was open-label, it tested a leave-on liquid applied twice daily rather than a shampoo, and it used the anagen percentage as its endpoint, not regrowth or density. A leave-on product that stays on the scalp for hours is not the same as a shampoo rinsed off after two minutes, and the trial does not prove the shampoo version works the same way.
What the shampoo trials actually tested
The shampoo-specific evidence is smaller and messier. A 2024 randomized trial in 84 participants found a shampoo with 0.4 percent caffeine plus 0.2 percent adenosine increased mean hair density from about 118 to 130 hairs per square centimeter over three months. A 2025 trial in 154 men found a caffeine plus DMG-Na shampoo improved the hair-pull test, minus 2.8 hairs against plus 0.6 for placebo. Both favored the active product, and both tested caffeine combined with something else, so the effect cannot be assigned to caffeine alone.
The systematic reviews agree on the direction and the quality. Szendzielorz and Spiewak's 2025 review in Healthcare covered nine studies and 684 participants, and found all nine reported findings favoring topical caffeine in at least one outcome. The same review rated most of the evidence low to very low quality by GRADE criteria, and noted women made up roughly 4.4 percent of the pooled population. A second 2025 review in the Journal of Drugs in Dermatology reached the same conclusion: caffeine appears safe and promising, and further large-scale randomized trials with standardized measures are needed.
How to use it, honestly
Treat caffeine shampoo as a low-risk add-on, never a standalone treatment for pattern hair loss. It is not FDA-approved for hair loss, there is no large randomized trial, and no long-term data beyond six months. The best-studied concentrations are 0.2 percent for leave-on products and 1 percent for shampoo, higher for rinse-off because contact time is shorter, and the shampoo needs about two minutes of contact before rinsing, because that is how long penetration takes.
Use it consistently, because caffeine is cleared from the follicle within 24 to 48 hours, so irregular use does not maintain local concentrations. And keep the hierarchy straight: minoxidil and finasteride have the trial data for pattern loss, and caffeine sits below both on evidence. A caffeine shampoo is a reasonable addition to a routine that already includes the proven treatments, not a replacement for them.
Related reading
Two earlier posts on this site cover ground “Caffeine Shampoo: What the Trials Actually Show” builds on: Panthenol on a Hair Label: Provitamin B5, Decoded, Cetrimonium Chloride vs Behentrimonium Chloride, and Guar Hydroxypropyltrimonium Chloride: The Lab Notes.
Frequently asked questions
Does caffeine shampoo work for hair loss?
It may help as a supporting treatment, but it should not replace better-established treatments for pattern hair loss. A 2017 trial found a 0.2 percent caffeine liquid non-inferior to 5 percent minoxidil, but it tested a leave-on liquid, not a shampoo, and a 2025 systematic review rated most of the evidence low to very low quality.
How long does caffeine need to stay on the scalp?
About two minutes. Fischer's 2007 study found caffeine reaches the hair follicle within two minutes of contact, and the follicle acts as a preferred route. Leave the shampoo on for two minutes before rinsing, and use it consistently, since caffeine clears from the follicle within 24 to 48 hours.
What concentration of caffeine works in shampoo?
The best-studied concentrations are 0.2 percent for leave-on products and 1 percent for shampoo formulations, higher for rinse-off because contact time is shorter. Most commercial caffeine shampoos list caffeine between 0.2 and 1 percent, but only two of nine studies in the 2025 review reported the actual concentration.
Is caffeine shampoo FDA approved for hair loss?
No. Topical caffeine is not FDA-approved for hair loss, there is no large randomized trial, and no long-term data beyond six months. Treat it as a low-risk add-on to a routine that already includes proven treatments, not as a standalone solution.